Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey

Introduction: Patients with cancer and hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are underrepresented in several clinical trials testing immune checkpoint inhibitors (ICIs). Consequently, safety and efficacy of ICI therapy in this population have not been completely defined. We ai...

Full description

Bibliographic Details
Published in:	JTO Clinical and Research Reports
Main Authors:	Marco Tagliamento, MD, Jordi Remon, MD, PhD, Matteo Giaj Levra, MD, Andrea De Maria, MD, Paolo Bironzo, MD, PhD, Benjamin Besse, MD, PhD, Silvia Novello, MD, PhD, Laura Mezquita, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Subjects:	Immune checkpoint inhibitors Cancer HBV HCV Immunotherapy Viral hepatitis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364322001709

Similar Items

Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum
by: Nika Kotnik, MD, et al.
Published: (2025-07-01)

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
by: Yasunori Murata, MD, PhD, et al.
Published: (2023-12-01)

Engineered immunologic niche monitors checkpoint blockade response and probes mechanisms of resistance
by: Ravi M. Raghani Ph.D., et al.
Published: (2024-06-01)

Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01)

Hepatitis B virus in oocytes and embryos: pregnancy outcomes and children’s health
by: Xiaoling Hu, Ph.D., et al.
Published: (2024-09-01)

Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma
by: Daisuke Hazama, MD, PhD, et al.
Published: (2024-01-01)

Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
by: Kana Hashimoto, MD, et al.
Published: (2024-11-01)

Long-term response of vulvar mucosal melanoma treated with neoadjuvant nivolumab
by: Margaux Dubus, MD, et al.
Published: (2023-08-01)

Hidradenitis suppurativa in the setting of immune checkpoint inhibitor therapy: A case series
by: Liam M. Dalton, BA, et al.
Published: (2025-05-01)

Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative
by: Gerardo Santos-López, et al.
Published: (2024-10-01)

Hepatitis C virus detection and management after implementation of universal screening in pregnancyAJOG Global Reports at a Glance
by: Sarah Boudova, MD, PhD, et al.
Published: (2024-02-01)

Severe Immune Checkpoint Inhibitor Hepatitis in KRAS G12C-Mutant NSCLC Potentially Triggered by Sotorasib: Case Report
by: Parvin Begum, MBChB.(Hons), et al.
Published: (2021-09-01)

Long-Term Efficacy of Immune Checkpoint Inhibitor for Squamous Cell Carcinoma Lesion Transformed From EGFR-Mutated Adenocarcinoma After Osimertinib Treatment: A Case Report
by: Shota Takahashi, MD, et al.
Published: (2024-02-01)

Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis
by: Shiting Xu, MD, et al.
Published: (2022-04-01)

Pull-through technique for hepatic vein angioplasty after liver transplantation
by: Eisuke Shibata, MD, PhD, et al.
Published: (2023-03-01)

Two-session embolization of portosystemic shunt presenting with hepatic encephalopathy via transvenous and trans-paraumbilical approaches: A case report
by: Hiroki Kamada, MD, PhD, et al.
Published: (2024-06-01)

Seroprevalence of hepatitis B, C, and D and associated factors in the semi-isolated Yanomami Amazonian indigenous community
by: Mariana Pinheiro Alves Vasconcelos, et al.
Published: (2024-01-01)

Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC
by: Yuto Terashima, MD, et al.
Published: (2023-11-01)

Imaging diagnosis of aberrant proper hepatic and gastroduodenal arteries prior to pancreaticoduodenectomy: A case report
by: Yosuke Namba, MD, et al.
Published: (2021-07-01)

Open surgical repair of a giant common hepatic artery pseudoaneurysm that perforated into the duodenum and common bile duct
by: Ken Tsuchida, MD, PhD, et al.
Published: (2023-09-01)

Immunoglobulin G4-related hepatic artery aneurysm
by: Kentaro Kasa, MD, et al.
Published: (2024-02-01)

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01)

Aberrant hepatic artery in an elderly patient with pancreatic head tumor
by: Giovanna Di Meo, MD, PhD, et al.
Published: (2023-12-01)

Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report
by: Yoshinari Endo, MD, et al.
Published: (2022-01-01)

Towards the elimination of viral hepatitis in Thailand by the year 2030
by: Nawarat Posuwan, et al.
Published: (2020-09-01)

Hepatic Reactive Lymphoid Hyperplasia and Primary Hepatic Lymphoma: Ultrasound Features and Differentiation Diagnosis
by: Xiaohui Qiao, MD, Kun Chen, MD, Gang Chen, MD, PhD, Liyun Xue, MD, Guangwen Cheng, MD, Hong Ding, MD, PhD
Published: (2021-06-01)

Monotherapy With Immune Checkpoint Blockade Improves Survival Outcomes in KRAS-Mutant but Not KRAS Wild-Type Metastatic Lung Adenocarcinoma: Validation From an Extended Swedish Cohort
by: Ella A. Eklund, MD, et al.
Published: (2025-10-01)

Strategies for screening and surveillance of high-risk populations for viral hepatitis in Japan
by: Peipei Song, et al.
Published: (2025-03-01)

J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan
by: Eisaku Miyauchi, MD, PhD, et al.
Published: (2025-03-01)

Hydatid cysts of the liver with concomitant massive peritoneal hydatidosis: a case report
by: Gjorgji Trajkovski, MD, PhD, et al.
Published: (2022-07-01)

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
by: Tomoya Kurokawa, MD, PhD, et al.
Published: (2023-05-01)

Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L
by: Hideyuki Harada, MD, PhD, et al.
Published: (2025-06-01)

Successful coil embolization of post-hepatectomy arterioportal fistula that reduced ascites and improved liver function
by: Ryuta Okuhira, MD, et al.
Published: (2024-06-01)

Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060
by: Takehiro Tozuka, MD, et al.
Published: (2024-04-01)

The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study
by: Jade N. Young, BS, et al.
Published: (2024-01-01)

CHRONIC VIRAL HEPATITIS В AND C IN CHILDREN BORN FROM MOTHERS INFECTED WITH НВV AND HCV
by: T. I. Raba
Published: (2017-03-01)

CD30+ lymphoproliferative disorder following immune checkpoint inhibition in a patient with Merkel cell carcinoma
by: Aneri Bhargav Patel, BS, et al.
Published: (2025-08-01)

Budd-Chiari syndrome secondary to retro-hepatic vena cava web: An unusual cause of epigastric pain
by: Manar Ezzahi, MD, et al.
Published: (2023-03-01)

Immune Checkpoint Inhibitors in Kidney Transplant Recipients: A French Multicenter Retrospective Cohort Study
by: Tristan Legris, MD, et al.
Published: (2025-09-01)

CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC
by: Antoine Desilets, MD, MSc, et al.
Published: (2024-12-01)